MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
75% survival in patients with severe respiratory distress treated with agenT-797agenT-797 improved lung function, significantly reduced inflammation and secondary infectionsMiNK to advance agenT-797... | May 22, 2023
Source: marketscreener.com